{"doi":"10.1111/dar.13384","title":"Abstracts","abstract":"Introduction: The United Nations Office on Drugs and Crime (UNODC) in line with its mandates works with families and communities in various low-and-middle income countries settings in the light of the International Standards for Prevention of Drug Use (UNODC/WHO, 2018) and the International Standards for the Treatment of Drug Use Disorders (UNODC/WHO, 2020). Method: Initial monitoring and evaluation results of UNODC supported science-and family-based programs will be shared. Key Findings: Families and communities are key to promote emotional, physical and social development and the achievement of the Sustainable Development Goals. Feasibility and effectiveness of different family prevention and family treatment programs has been demonstrated across many countries. Discussions and Conclusions: Family factors and contexts in which families live can be both a risk a protective factor when it comes to the onset of drug use and the development of drug use disorders. Effective programs and interventions on various levels can enhance the supportive potential of families in the creation of societies more resilient to drugs and crime. There is a need for further monitoring and evaluation of interventions in different contexts. Implications for Practice or Policy: A key role in the mandates of UNODC is to provide technical assistance and thus translate science to practice in support of United Nations Member States on effective drug use disorder prevention, treatment and care. Implications for Translational Research: The work presented includes information from implementation studies on evidencebased interventions adapted to in low-and middle-income countries. Disclosure of Interest Statement: AB is a staff member of the United Nations. The author alone is responsible for the views expressed in this presentation","journal":"Drug and Alcohol Review","year":2021,"id":218107,"datarank":0.27089070397840304,"base_score":1.3862943611198906,"endowment":1.3862943611198906,"self_citation_contribution":0.20794415416798362,"citation_network_contribution":0.06294654981041943,"self_endowment_contribution":0.20794415416798362,"citer_contribution":0.06294654981041943,"corpus_percentile":42.275856733967665,"corpus_rank":7463,"citation_count":3,"citer_count":3,"citers_with_citation_signal":2,"citers_with_endowment":2,"datacite_reuse_total":0,"is_dataset":true,"is_dataset_confidence":0.545,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2021-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":815931,"name":"Cale, J.","orcid":null,"position":1,"is_corresponding":false},{"id":815932,"name":"Nathan, S.","orcid":null,"position":2,"is_corresponding":false},{"id":815933,"name":"Bista, S.","orcid":null,"position":3,"is_corresponding":false},{"id":815934,"name":"Ferry, M.","orcid":null,"position":4,"is_corresponding":false},{"id":815935,"name":"Williams, M.","orcid":null,"position":5,"is_corresponding":false},{"id":815936,"name":"Rawstorn, P.","orcid":null,"position":6,"is_corresponding":false},{"id":815937,"name":"Hayen, A.","orcid":null,"position":7,"is_corresponding":false},{"id":815930,"name":"Whitten, T.","orcid":null,"position":0,"is_corresponding":true}],"reference_count":99,"raw_metadata":null,"created_at":"2026-07-18T23:53:24.683898Z","pmid":"34741479","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}